Supervisory board

EQS-News: OHB SE: Consolidated financial statements 2023

Retrieved on: 
Friday, May 3, 2024

In fiscal year 2023, the OHB Group (ISIN: DE0005936124, Prime Standard) generated total revenues of EUR 1,182.8 (previous year: EUR 1,001.3 million), while sales changed to EUR 1,047.8 million (previous year: EUR 944.5 million).

Key Points: 
  • In fiscal year 2023, the OHB Group (ISIN: DE0005936124, Prime Standard) generated total revenues of EUR 1,182.8 (previous year: EUR 1,001.3 million), while sales changed to EUR 1,047.8 million (previous year: EUR 944.5 million).
  • The operating EBITDA margin thus rose to 13.7 % in the reporting period, compared to 9.9 % in the previous year.
  • The Management Board expects consolidated total revenues to increase to between EUR 1,300 and 1,400 million in 2024.
  • OHB SE's complete 2023 consolidated financial statements will be presented in detail at today's hybrid annual press conference in Bremen and the subsequent virtual analyst conference.

EQS-News: Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.

Retrieved on: 
Friday, May 3, 2024

Dirk Brüse and Lode Fastré new members of the Managing Board.

Key Points: 
  • Dirk Brüse and Lode Fastré new members of the Managing Board.
  • Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items.
  • Dirk Brüse and Lode Fastré new members of the Managing Board.
  • As long-standing members of Redcare Pharmacy´s Senior Management Dirk Brüse and Lode Fastré have been mentored by Stephan Weber and Marc Fischer for many years.

EQS-News: Fourth acquisition in 2024: Mutares has successfully completed the acquisition of Greenview Group Holdings Ltd from Cordovan Capital Management Ltd and its current management

Retrieved on: 
Friday, May 3, 2024

Munich, April 22, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has successfully completed the acquisition of Greenview Group Holdings Ltd from Cordovan Capital Partners II LP and Michael Burke, the group’s current CEO.

Key Points: 
  • Munich, April 22, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has successfully completed the acquisition of Greenview Group Holdings Ltd from Cordovan Capital Partners II LP and Michael Burke, the group’s current CEO.
  • EUR 36 million in 2023 and is forecast to deliver EUR 45 million in the current financial year to March 2025.
  • As the portfolio grows, so do consulting revenues, which together with portfolio dividends and exit proceeds accrue to the Mutares Holding.
  • The Management Board and Supervisory Board together hold more than one-third of all Mutares shares with voting rights.

EQS-News: SURTECO GROUP SE: Good start to the business year 2024 after a difficult year in 2023

Retrieved on: 
Friday, May 3, 2024

Buttenwiesen, 24 April 2024 – The sales of the SURTECO Group at € 835.1 million in the business year 2023 (2022: € 747.7 million) were in the range most recently expected.

Key Points: 
  • Buttenwiesen, 24 April 2024 – The sales of the SURTECO Group at € 835.1 million in the business year 2023 (2022: € 747.7 million) were in the range most recently expected.
  • After taking the one-off exceptional effects into account, the Group generated adjusted EBITDA of € 86.4 million (2022: € 84.2 million) in the business year 2023.
  • SURTECO made a good start to the business year 2024 with preliminary sales of € 222.3 million (2023: € 205.7 million) and preliminary adjusted EBITDA of € 27.6 million (2023: € 19.1 million).
  • SURTECO GROUP SE with registered office in Buttenwiesen is a mid-sized enterprise listed on the stock exchange with international operations.

EQS-News: BRAIN Biotech AG takes next step to optimize group structure

Retrieved on: 
Friday, May 3, 2024

BRAIN Biotech Group will merge AnalytiCon Discovery GmbH into BRAIN Biotech AG in order to further optimize and simplify the Group structure.

Key Points: 
  • BRAIN Biotech Group will merge AnalytiCon Discovery GmbH into BRAIN Biotech AG in order to further optimize and simplify the Group structure.
  • Zwingenberg, Germany, 16 April 2024 – The Management Board of BRAIN Biotech AG, with the approval of the Supervisory Board, has resolved to merge AnalytiCon Discovery GmbH with BRAIN Biotech AG.
  • AnalytiCon Discovery GmbH, based in Potsdam, Germany, is already a fully owned subsidiary of the BRAIN Biotech Group.
  • This legal reorganization will further optimize and simplify the structure of the BRAIN Biotech Group.

Medigene AG reports Financial Results and Business Update for Q1 2024

Retrieved on: 
Friday, April 26, 2024

Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results for the first quarter of 2024.

Key Points: 
  • Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results for the first quarter of 2024.
  • The full Quarterly Statement Q1 2024 can be downloaded here: https://medigene.com/investors-media/reports-presentations/ .
  • The financial performance in Q1 2024 was in line with the Executive Management Board’s expectations.
  • The subscription period for the new shares commenced on April 24, 2024 and ends on May 7, 2024 at 24:00 hours (CEST).

Sono Group N.V. Announces Ticker Symbol Update and New Leadership Team as It Prepares for Market Advancement

Retrieved on: 
Friday, April 26, 2024

This change marks the end of the bankruptcy indication for Sono Group N.V., and the Company's ordinary shares will be quoted on the over-the-counter market under the US ticker symbol SEVC going forward.

Key Points: 
  • This change marks the end of the bankruptcy indication for Sono Group N.V., and the Company's ordinary shares will be quoted on the over-the-counter market under the US ticker symbol SEVC going forward.
  • In addition, Sono Group N.V. has submitted its application for admission to trading on OTCQB, which is intended to generate additional liquidity in the Company’s shares and facilitate investor activity.
  • George O'Leary has taken the helm as the new Managing Director, CEO, and CFO of Sono Group N.V., officially beginning his tenure on January 31, 2024.
  • The Company believes that Mr. O’Leary’s diverse expertise uniquely positions him to steer Sono Group N.V. towards a robust future.

ASML discloses 2024 AGM results

Retrieved on: 
Wednesday, April 24, 2024

Veldhoven, the Netherlands, April 24, 2024 – ASML Holding N.V. (ASML) today announces the results of its Annual General Meeting (AGM) held on April 24, 2024.

Key Points: 
  • Veldhoven, the Netherlands, April 24, 2024 – ASML Holding N.V. (ASML) today announces the results of its Annual General Meeting (AGM) held on April 24, 2024.
  • The 2024 AGM marks the end of the terms of Peter Wennink and Martin van den Brink as Presidents of ASML and the beginning of Christophe Fouquet's term as President and CEO of ASML.
  • At the AGM, ASML’s statutory financial statements for the 2023 financial year were adopted.
  • The following subjects were also discussed at the AGM:
    The composition of the Supervisory Board in 2025: Birgit Conix and Annet Aris will retire by rotation per the 2025 AGM
    The presentation given at the AGM and the recording of the webcast are available on the 2024 AGM page.

Publicis Groupe proposes change to its governance structure

Retrieved on: 
Wednesday, April 17, 2024

This change would see the company shift from a dual structure corporation with a Supervisory Board and Management Board (Directoire), and instead adopt the more widespread model of a single structure corporation with a Board of Directors.

Key Points: 
  • This change would see the company shift from a dual structure corporation with a Supervisory Board and Management Board (Directoire), and instead adopt the more widespread model of a single structure corporation with a Board of Directors.
  • “Publicis Groupe has a long history of anticipating change and transforming itself to face the future” commented Maurice Lévy, Chairman of the Supervisory Board.
  • “The primary responsibility of any board is to ensure that a company has both the governance structure and the teams it needs to lead it forward.
  • For those reasons, I hope that our shareholders will support this proposal” said Arthur Sadoun, Chairman and CEO of Publicis Groupe.

Annual General Meeting 2024 Resolutions (correction of dividend record date)

Retrieved on: 
Monday, April 15, 2024

SBM Offshore announces with reference to the press release published on April 12, 2024, a correction of the dividend record date as per the updated text below.

Key Points: 
  • SBM Offshore announces with reference to the press release published on April 12, 2024, a correction of the dividend record date as per the updated text below.
  • SBM Offshore is pleased to announce that all resolutions were adopted as proposed during the Annual General Meeting of April 12, 2024.
  • Shareholders also voted in favor of the proposed all cash dividend of US$150 million, which represents a dividend distribution of US$0.8336 per ordinary share.
  • The cash dividend is payable on May 10, 2024 to all shareholders of record as at April 17, 2024 through the bank or broker administering the shares.